Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria

Table 1

Demographical and clinical data: chronic spontaneous urticaria patient group and control group.

		CSU^† patient group	Control group	p Value
Age (average ± s.s.)		39.83 ± 11.67	31.85 ± 6.77
Disease duration (months); (average ± s.s.); (median (min–max))
		59.97 ± 77.51; 18.5 (3–252)
Gender (n(%))	Woman	24 (80)	10 (50)
	Man	6 (20)	10 (50)
Comorbidity (n(%))	(+)	8 (26.67)	0 (0)
	(−)	22 (73.33)	20 (100)
Angioedema (n(%))	(+)	19 (63.33)
	(−)	11 (36.67)

Note: t-test and Chi-square tests. ^†Chronic spontaneous urticaria.